Evidence map›Paper›PMID 29700068›Full record

ReviewCirculation research2018

Advances in Transcriptomics: Investigating Cardiovascular Disease at Unprecedented Resolution.

Robert C Wirka, Milos Pjanic, Thomas Quertermous

Open access · bronzeAbstract readReview
In one paragraph

Review in Circulation research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Transcriptional characterization of sepsis in a LPS porcine model.Molecular genetics and genomics : MGG · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. [Application of RNA sequencing in clinical diagnosis of Mendelian disease].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Robert C WirkaFrom the Department of Medicine, Division of Cardiovascular Medicine, Stanford University, CA.
Milos PjanicFrom the Department of Medicine, Division of Cardiovascular Medicine, Stanford University, CA.
Thomas Quertermous
Cardiovascular Institute of the South · US

Funding

Causal variant association mechanisms in TCF21 binding coronary disease lociR01HL134817 · NHLBI · STANFORD UNIVERSITY · PI THOMAS QUERTERMOUS · 2017 to 2026
$6.2M
Mechanism of the Coronary Heart Disease Association at Chromosome 6q23.2R01HL109512 · NHLBI · STANFORD UNIVERSITY · PI QUERTERMOUS, THOMAS · 2011 to 2019
$6.1M
The SMAD3 signaling network in coronary artery disease riskR01HL139478 · NHLBI · STANFORD UNIVERSITY · PI THOMAS QUERTERMOUS · 2018 to 2026
$3.7M
Identification and study of the vascular disease gene at 9p21.3R01HL103635 · NHLBI · STANFORD UNIVERSITY · PI QUERTERMOUS, THOMAS · 2010 to 2013
$2.4M
Molecular Mechanisms of Insulin Resistance Associated LociR01DK107437 · NIDDK · STANFORD UNIVERSITY · PI QUERTERMOUS, THOMAS · 2016 to 2019
$2.2M
Identification of causal coronary heart disease variation in smooth muscle cellsR33HL120757 · NHLBI · STANFORD UNIVERSITY · PI QUERTERMOUS, THOMAS · 2016 to 2018
$1.6M
Identification of causal coronary heart disease variation in smooth muscle cellsR21HL120757 · NHLBI · STANFORD UNIVERSITY · PI QUERTERMOUS, THOMAS · 2014 to 2015
$434k
The role of TCF21 in coronary heart diseaseF32HL129670 · NHLBI · STANFORD UNIVERSITY · PI WIRKA, ROBERT · 2015 to 2017
$192k
NHLBI NIH HHS F32 HL129670NHLBI NIH HHS R01 HL103635NHLBI NIH HHS R01 HL109512NHLBI NIH HHS R01 HL134817NHLBI NIH HHS R01 HL139478NHLBI NIH HHS R21 HL120757NHLBI NIH HHS R33 HL120757NIDDK NIH HHS R01 DK107437
6 · The paper itself

Abstract

Whole-genome transcriptional profiling has become a standard genomic approach to investigate biological processes. RNA sequencing (RNAseq) in particular has witnessed myriad applications in genetics and various biomedical fields. RNAseq involves a relatively simple experimental protocol of RNA extraction and cDNA library preparation and, because of decreasing next-generation sequencing cost and lower computational burden for data processing, has obtained a central role in the modern biology. The recent application of RNAseq methodology to single-cell transcriptional profiling has enabled the more precise characterization of cell lineage and cell state genetic profiles. The development of bioinformatic and statistical tools has provided for differential gene expression analysis, RNA isoform analysis, haplotype-specific analysis of gene expression (allele-specific expression), and analysis of expression quantitative trait loci. We give an overview of these and recent developments in RNAseq methodology with emphasis on quality control, read mapping, feature counting, differential gene expression, allele-specific expression and expression quantitative trait loci analysis, and fusion transcript detection. We describe utilization of RNAseq as a diagnostic tool in Mendelian diseases, complex phenotypes, and cancer and give an overview of long read RNAseq technology. Furthermore, we discuss in detail the recent revolution in single-cell transcriptomics that is reshaping modern biology.

Indexed as

Sequence Analysis, RNATranscriptomeAllelesAnimalsCardiovascular DiseasesCell LineageDNA, ComplementaryGene Expression ProfilingGene Expression RegulationGene LibraryHigh-Throughput Nucleotide SequencingHumansMolecular Diagnostic TechniquesOligonucleotide Array Sequence AnalysisQuantitative Trait LociSingle-Cell AnalysisDNA, Complementarygene expressiongenomicsquantitative trait lociRNA isoformssingle cell

Identifiers

PMID29700068
PMCPMC7274217
OpenAlexW2889204820

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.